Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Crystallization (Commentary)

show results
Don't show organism specific information (fast!)
Search organism in taxonomic tree (slow, choose "exact" as search mode, e.g. "mammalia" for rat,human,monkey,...)
(Not possible to combine with the first option)
Refine your search

Search term:

Results 1 - 10 of 12 > >>
EC Number Crystallization (Commentary)
Show all pathways known for 3.2.1.26Display the word mapDisplay the reaction diagram Show all sequences 3.2.1.26-
Show all pathways known for 3.2.1.26Display the word mapDisplay the reaction diagram Show all sequences 3.2.1.262.6 A crystal structure of cell-wall invertase 1 in complex with a protein inhibitor, cell-wall inhibitor of beta-fructosidase, from tobacco. The structure recognizes a small amino acid motif in the inhibitor that directly targets the invertase active site. The activity of INV1 and its interaction with inhibitor are strictly pH-dependent with a maximum at about pH 4.5. At this pH, isothermal titration calorimetry reveals that the inhibitor tightly binds its target with nanomolar affinity. Cell wall inhibitor of beta-fructosidase competes with sucrose for the same binding site
Show all pathways known for 3.2.1.26Display the word mapDisplay the reaction diagram Show all sequences 3.2.1.26apo form of beta-fructofuranosidase and its complex with fructose, both to 1.8 A resolution. Enzyme consists of the N-terminal five-blade beta-propeller domain that includes the catalytic site, as well as the beta-sandwich C-terminal domain. The active site is located at the bottom of the axial funnel created by the interblade loops and the loops between beta-strand 2-3 of each blade. The protein has a 35-residue elongation of the N-terminus containing a fiveturn alpha-helix, which distinguishes it from the other known members of the GH32 family
Show all pathways known for 3.2.1.26Display the word mapDisplay the reaction diagram Show all sequences 3.2.1.26both native and SeMet-substituted InvB are concentrated to 5-10 mg/ml by ultrafiltration for crystallization. Crystals are grown at 16°C using the hanging drop vapor diffusion method
Show all pathways known for 3.2.1.26Display the word mapDisplay the reaction diagram Show all sequences 3.2.1.26hanging drop vapour diffusion method using 22.5-28% PEG 8000 or 25% PEG 4000 as a precipitant in 0.1 M cacodylate pH 6.5 and 0.1 M zinc acetate
Show all pathways known for 3.2.1.26Display the word mapDisplay the reaction diagram Show all sequences 3.2.1.26hanging drop vapour diffusion method, in complex with cell-wall inhibitor of beta-fructosidase, at pH 7.0 with sodium formate as precipitant, with PEG 4000, NaI at pH 7.5-9.5 or with PEG 4000 and Li2SO4 at pH 4.6 and 5.0, respectively
Show all pathways known for 3.2.1.26Display the word mapDisplay the reaction diagram Show all sequences 3.2.1.26partial proteolysis and multiple sequence alignment indicate that both N and C termini are somewhat unstructured. Thus, we overexpressed and purified a truncated version of InvA (residues Lys9-Thr460) and successfully optimized its crystal co-crystallized with 200 mM fructose, the 2.11 A SeMet-substituted crystal of which was used for structure determination. In the sucrose-complexed structure (InvA-Suc), which has a space group of C2221, each asymmetric unit contains three molecules of InvA
Show all pathways known for 3.2.1.26Display the word mapDisplay the reaction diagram Show all sequences 3.2.1.26purified recombinant His-tagged wild-type and selenomethionine-labeled enzyme, vapour diffusion method, 11 mg/ml wild-type enzyme in 15% PEG 1000, 150 mM Li2SO4, and 100 mM sodium citrate, pH 4.2, 3 days, 20°C, conditions for the selenomethionine-labeled enzyme: 8 mg/ml protein in 17% PEG 1000, 50 mM Li2SO4, 1% isopropanol, and 100 mM sodium citrate, pH 4.2, X-ray diffraction structure determination and analysis at 2.0-2.2 A resolution
Show all pathways known for 3.2.1.26Display the word mapDisplay the reaction diagram Show all sequences 3.2.1.26purified recombinant inactivated mutant enzyme E190D in complex with substrate raffinose, hanging drop vapour diffusion method, 11 mg/ml protein in 15-17% PEG 1000, 150 mM Li2SO4, and 100 mM sodium citrate, pH 4.2, soaking of crystals in 5 mM substrate solution, flash freezing at -173°C, X-ray diffraction structure determination and analysis at a.87 A resolution, structure modelling, no successful crystal structure analysis with crystals of wild-type enzyme and mutant E190A built by the same method
Show all pathways known for 3.2.1.26Display the word mapDisplay the reaction diagram Show all sequences 3.2.1.26sitting drop vapor diffusion method, using 3% (w/v) PEG 3350, 5% (w/v) 2-methyl-2,4-pentanediol, 0.6 M magnesium formate, 1 mM tris(2-carboxyethyl)phosphine, 0.33 M guanidinium chloride, and 0.1 Bis-Tris (pH 6.5)
Results 1 - 10 of 12 > >>